Announcement on Entrusted Financial Management in Q2 2025
Filed with SSE · · 4 pages · Chinese
Jointown Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Jointown Pharmaceutical
- Announcement on the Completion of Filing for the Industry Fund Established by Wholly-Owned Subsidiary
- Announcement on Obtaining Drug Registration Certificate for Dexamethasone Sodium Phosphate Injection
Later from Jointown Pharmaceutical
- Announcement on Expiration of Duration and Termination of Phase III Employee Stock Ownership Plan in 2022
- Announcement on Upgrading Subject Credit Rating to AAA
- Announcement on Resolutions of the 16th Meeting of the 6th Board of Directors
- Announcement on Outline of the 2025 Semi-annual Performance Briefing
- Announcement on Participating in the Establishment of Industrial Fund and Related Party Transactions
Follow Jointown Pharmaceutical into a list and get an email when it puts out news.
Follow Jointown Pharmaceutical